newsfilter
← Latest News
Business Wire·

Adicet Bio Reports First Quarter 2025 Financial Results and Provides Business Updates

Two programs with clinical data readouts in 2H/2025 Phase 1 clinical trial of ADI-001 in autoimmune diseases ongoing with preliminary clinical data expected in 2H/2025; Trial now open for enrollment to patients with